Stem Cell Therapy Fund Inc is categorized under Rehabilitation Center, Outpatient Treatment in San Juan Capistrano, CA and active since 2010.
Stem Cell Therapy Fund Inc was established in 2010, and today employs 1 to 4, earning Unknown per year. This is a Rehabilitation Center, Outpatient Treatment business, which does work in the B2C market, and is classified as a Rehabilitation Center, Outpatient Treatment, under code number 621498 by the NAICS.
If you are seeking more information, feel free to contact Mark Daniel Deckard at the company’s single location by writing to 27543 Paseo Tamara, San Juan Capistrano, California CA 92675 or by phoning (415) 876-6292. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Stem Cell Therapy Fund Inc |
Contact Person: | Mark Daniel Deckard |
Address: | 27543 Paseo Tamara, San Juan Capistrano, California 92675 |
Phone Number: | (415) 876-6292 |
Annual Revenue (USD): | Unknown |
Founded: | 2010 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2C (Business to Consumer) |
Business Category: | Rehabilitation Center, Outpatient Treatment |
SIC Code: | 8093 |
NAICS Code: | 621498 |
Share This Business: |
Stem Cell Therapy Fund Inc was started in 2010 to provide professional Rehabilitation Center, Outpatient Treatment under the SIC code 8093 and NAICS code 621498. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Mark Daniel Deckard for inquiries that concern Stem Cell Therapy Fund Inc by calling the company number (415) 876-6292, as your correspondence is most welcome. Additionally, the physical location of the single location of Stem Cell Therapy Fund Inc can be found at the coordinates as well as the street address 27543 Paseo Tamara in San Juan Capistrano, California 92675.
For its online presence, you may visit Stem Cell Therapy Fund Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.